Reneo Pharmaceuticals
Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies.
2
Funding Rounds
$145.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro***** Bl*** | - | - | - |
| Er** Du** | - | - | - |
| St**** Se***** | - | - | |
| Pa** W. Ho******* | - | - | |
| Gr***** J. Fl***** | - | - | - |
| Ni*** O'******* | - | - | - |
| Ed Ma***** | - | - | |
| Mi** Gr** | - | - | - |
| Ba** Mu******** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Reneo Pharmaceuticals has raised a total of $145m in funding over 2 rounds.
Key Insights:
- Reneo Pharmaceuticals Series B round, December 2020: $95m
- Reneo Pharmaceuticals Series A round, May 2019: $50m
Reneo Pharmaceuticals Series B round, December 2020
$95m
Reneo Pharmaceuticals Series A round, May 2019
$50m
Industries
Reneo Pharmaceuticals is active in the following industries:
- Engineering
- Biology
- Biotechnology
- Biomedical engineering
- Technology